Skip to main content
. Author manuscript; available in PMC: 2020 Dec 3.
Published in final edited form as: Clin Cancer Res. 2019 Aug 30;25(23):7113–7125. doi: 10.1158/1078-0432.CCR-19-1700

Figure 1.

Figure 1.

Overall distribution of molecular alterations and histologic/molecular correlation of tumor clonality typing. A, Shared and unique mutations in NGS-defined IPMs. B, Shared and unique mutations in NGS-defined SPLCs. C, Comparison of prospective histologic prediction with clonality defined by NGS. D, Comparison of histology-molecular concordance rate when NGS testing was suggested versus not suggested by the pathologist.